Caisse De Depot Et Placement Du Quebec Alnylam Pharmaceuticals, Inc. Transaction History
Caisse De Depot Et Placement Du Quebec
- $47 Billion
- Q4 2024
A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 10,018 shares of ALNY stock, worth $2.49 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,018
Previous 25,295
60.4%
Holding current value
$2.49 Million
Previous $6.96 Million
66.13%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding ALNY
# of Institutions
667Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.13 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.17 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.38 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.73 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.09 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...